Skip to main content
Monika (Dwivedi) Joshi, MD, Oncology, Hershey, PA, Penn State Milton S. Hershey Medical Center

Monika(Dwivedi)JoshiMDMRCP

Oncology Hershey, PA

Hematologic Oncology

Associate Professor

Dr. Joshi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Joshi's full profile

Already have an account?

Education & Training

  • Penn State Milton S Hershey Medical Center
    Penn State Milton S Hershey Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
  • UPMC Medical Education (Harrisburg)
    UPMC Medical Education (Harrisburg)Residency, Internal Medicine, 2007 - 2010
  • Kasturba Medical College Manipal
    Kasturba Medical College ManipalClass of 2001

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2007 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Original Contribution Mitotic Activity in Non-Invasive Papillary Urothelial Carcinoma: Its Value in Predicting Tumor Recurrence, and Comparison to the Contemporary Two...  
    Augustyna Gogoj, Suzanne B Merrill, Monika Joshi, Sheldon Holder, Joshua I Warrick, Matthew Kaag, Jay D Raman, Joseph Drabick, ScienceDirect

Authored Content

  • Advances in Treatments for Genitourinary Malignancies Provide Silver Lining to 2020October 2020

Press Mentions

  • Monika Joshi, MD, on Geographic Disparities in Urothelial Cancer Care
    Monika Joshi, MD, on Geographic Disparities in Urothelial Cancer CareJuly 1st, 2022
  • Need for a Personalized Approach for Muscle Invasive Bladder Cancer: Role of Tumor Biology in Response to Neoadjuvant Chemotherapy
    Need for a Personalized Approach for Muscle Invasive Bladder Cancer: Role of Tumor Biology in Response to Neoadjuvant ChemotherapyDecember 4th, 2018
  • DDR Mutations Linked to Improved Urothelial Cancer Outcomes
    DDR Mutations Linked to Improved Urothelial Cancer OutcomesJune 15th, 2019
  • Join now to see all

Hospital Affiliations